Aditxt Corp (ADTX): Total Asset Value of Company
Market fluctuations in Aditxt (ADTX) share prices reflect the dynamics of total assets, which currently stand at 0.00. The business relies on external contractors to conduct analyses, creating a specific dependency on partners. Aditxt is implementing advanced immune system control methods to extend life, although it is currently attempting to restore shareholder confidence following frequent revisions to its capital structure.
Comprehensive metric breakdowns and analytics for aditxt.com (ADTX)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Fundamental valuation:ADTX, Aditxt Corp
An analysis of the total capital and liabilities structure of Aditxt (ADTX) allows for an assessment of the company's resource scale against the backdrop of patent protection and FDA regulatory barriers, which are offset by financial instability. This indicator reflects the total value of assets and debts, calculated inversely via return on assets (ROA) to determine the actual size of the business, while a sharp increase in the metric may signal risky leverage.
Competitors of Aditxt (ADTX)
ARGX (argenx.com) - Total Business Assets|Aggregate Company Assets BioNTech BNTX|Total Asset Value of Company Abivax|ADMA Bio (ADMA) - Company Total Assets|Aggregate Asset Value Protagonist Corp (PTGX)|Company Total Assets IMVT (Immunovant, Inc.)|kiniksa.com - Company Total Assets|Aggregate Company Assets Grifols (GRFS)|ADPT: Aggregate Asset Value|CLDX (Celldex) - Aggregate Company Assets|Aurinia Corp (AUPH) - Cumulative Company Assets|BCRX (BioCryst) - Company Total Assets|Company Total Assets veratx.com (VERA)|Dianthus Therapeutics, Inc. (DNTH) - Cumulative Company Assets|Aggregate Asset Value Pharvaris NV (PHVS)|Company Total Assets ABCL|Tourmaline - Company Total Asset Base|PGEN: Aggregate Company Assets|PHAR: Cumulative Company Assets|NKTR (Nektar Therapeutics Inc.) - Aggregate Company Assets|Cumulative Company Assets Upstream Bio, Inc.|ZBIO (Zenas Biopharma, Inc.) - Cumulative Company Assets|Company Total Assets IMNM|Aggregate Company Assets Gossamer Bio, Inc. GOSS|Total Business Assets kalvista.com (KALV)|SEPN: Company Total Assets|Company Assets Pieris Pharma PVLA|Savara Corp - Company Total Assets|RIGL - Company Total Assets|Company Total Assets AnaptysBio, Inc.|astriatx.com (ATXS) - Total Business Assets|ENGN: Company Total Assets|Company Total Asset Base RAPT Therapeutics Inc. (RAPT)|Cumulative Company Assets Aerovate Therapeutics Inc|Aggregate Business Assets Aclaris Therapeutics, Inc ACRS|KYTX - Cumulative Company Assets|TLSA - Total Business Assets|Cumulative Company Assets Cabaletta Bio CABA|VTYX - Aggregate Business Assets|THTX: Company Total Assets|Avalo Therapeutics Inc (AVTX) - Company Total Assets|Company Total Assets Eledon Pharmaceuticals (ELDN)|Total Business Assets agenusbio.com (AGEN)|Cumulative Company Assets Climb Bio|Aggregate Business Assets Zura Bio Ltd ZURA|ATYR - Cumulative Company Assets|Adagene Inc - Total Business Assets|Aggregate Company Assets Ikena Oncology, Inc.|STTK - Total Asset Value of Company|Company Total Assets equilliumbio.com EQ|Connect Biopharma Holdings Limited (CNTB) - Aggregate Asset Value|IMUX (Immunic Therapeutics) - Company Total Assets|Company Total Assets ATRA|InflaRx N.V. (IFRX) - Aggregate Company Assets|Aggregate Asset Value XFOR (x4pharma.com)|Adicet Bio, Inc. - Aggregate Company Assets|Cumulative Company Assets Celularity Inc CELU|INmune Bio Corp - Company Total Assets|Barinthus Biotherapeutics Corp (BRNS) - Company Total Assets|Cumulative Company Assets Kezar Life Sciences KZR|sabbiotherapeutics.com (SABS) - Aggregate Asset Value|AKTX: Company Total Assets|Company Total Asset Base ENLV|Aggregate Company Assets QTTB (Q32 Bio Inc.)|Cumulative Company Assets GOVX (GeoVax Corp)|Edesa Biotech, Inc. - Aggregate Company Assets|IBIO - Cumulative Company Assets|Carisma Tx - Cumulative Company Assets|XTLB: Company Total Assets|Aggregate Company Assets boltbio.com|HCW Biologics (HCWB) - Total Business Assets|Company Total Assets APVO (Aptevo Therapeutics, Inc.)|Company Assets AIM ImmunoTech, Inc.|Company Total Assets GRI|Company Total Assets XORTX Therapeutics Inc (XRTX)|HIND - Company Total Assets|Total Business Assets Revelation Biosciences Corp REVB|Company Total Assets INDP (Indaptus Therapeutics)|scinai.com (SCNI) - Company Total Asset Base|CALI - Cumulative Company Assets|Aggregate Business Assets Affimed N.V.|Cumulative Company Assets Allakos Inc (ALLK)|Total Business Assets HOOKIPA (HOOK)|Cumulative Company Assets IGM Biosciences, Inc.|Aggregate Business Assets iteostherapeutics.com (ITOS)|Company Total Assets OCEA (Ocean Biomedical)|Company Total Assets TC BioPharm (Holdings) Plc TCBP|Third Harmonic Bio, Inc (THRD) - Company Total Assets